Meet 17 new Seeking Alpha analysts and explore their debut stock ratings, investment theses, and market insights.
Celestica shows strong HPS growth and expanding margins, but limited upside and stretched valuation cap further gains. Read ...
AI is still Wall Street's favorite trade, but there's a corner of the sector that's crushing the broader market since the ...
Back in August when the 14F filings deadline had passed I wrote about some of the latest picks of UK-based growth investment ...
At least, that's the case with Bristol Myers Squibb ( BMY 0.92%), Pfizer ( PFE 0.29%), and Dentsply Sirona ( XRAY +0.97%).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback